Jonathan Larkin

2.4k total citations · 1 hit paper
45 papers, 1.4k citations indexed

About

Jonathan Larkin is a scholar working on Rheumatology, Pharmacology and Molecular Biology. According to data from OpenAlex, Jonathan Larkin has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 15 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Jonathan Larkin's work include Osteoarthritis Treatment and Mechanisms (26 papers), Inflammatory mediators and NSAID effects (15 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Jonathan Larkin is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (26 papers), Inflammatory mediators and NSAID effects (15 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Jonathan Larkin collaborates with scholars based in United States, Denmark and United Kingdom. Jonathan Larkin's co-authors include Ali Mobasheri, Anne‐Christine Bay‐Jensen, Simon J. Slater, Mark D. Yeager, Mary Beth Kelly, Christopher D. Stubbs, Cojen Ho, Frank J. Taddeo, Mark A. Feitelson and W.E. van Spil and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Jonathan Larkin

43 papers receiving 1.4k citations

Hit Papers

Osteoarthritis endotype discovery via clustering of bioch... 2022 2026 2023 2024 2022 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Osteoarthritis endotype discovery via clustering of biochemical marker data
    2022 97 citations Federico Angelini, Paweł Widera et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Larkin United States 22 603 423 225 201 178 45 1.4k
Abdelhamid Liacini United States 12 433 0.7× 455 1.1× 280 1.2× 132 0.7× 85 0.5× 48 1.4k
Hiroshi Matsushima Japan 24 146 0.2× 511 1.2× 84 0.4× 270 1.3× 336 1.9× 75 1.8k
Bernhard J. Kirschbaum Germany 16 512 0.8× 756 1.8× 167 0.7× 114 0.6× 124 0.7× 20 1.6k
Kazuhiko Yamamura Japan 23 229 0.4× 595 1.4× 46 0.2× 249 1.2× 117 0.7× 52 1.7k
Sally Thomas United Kingdom 14 147 0.2× 494 1.2× 52 0.2× 403 2.0× 201 1.1× 26 1.6k
Pércío S. Gulko United States 27 832 1.4× 801 1.9× 70 0.3× 117 0.6× 60 0.3× 78 2.1k
Elizabeth A. Chlipala United States 22 252 0.4× 470 1.1× 66 0.3× 89 0.4× 93 0.5× 37 1.3k
Anne M. Fourie United States 18 547 0.9× 677 1.6× 222 1.0× 93 0.5× 159 0.9× 32 2.0k
Hirohisa Ogawa Japan 24 62 0.1× 556 1.3× 90 0.4× 178 0.9× 125 0.7× 89 1.6k
Masayuki Tsuchiya Japan 23 94 0.2× 869 2.1× 69 0.3× 133 0.7× 101 0.6× 39 1.9k

Countries citing papers authored by Jonathan Larkin

Since Specialization
Citations

This map shows the geographic impact of Jonathan Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Larkin more than expected).

Fields of papers citing papers by Jonathan Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Larkin. The network helps show where Jonathan Larkin may publish in the future.

Co-authorship network of co-authors of Jonathan Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Larkin. A scholar is included among the top collaborators of Jonathan Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Larkin. Jonathan Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannani, Monica T., Christian S. Thudium, Alfred Gellhorn, et al.. (2024). Longitudinal stability of molecular endotypes of knee osteoarthritis patients. Osteoarthritis and Cartilage. 33(1). 166–175. 4 indexed citations
2.
Loef, M., Stefan Böhringer, Anne‐Christine Bay‐Jensen, et al.. (2022). The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort. Osteoarthritis and Cartilage. 30(8). 1062–1069. 18 indexed citations
3.
Angelini, Federico, Paweł Widera, Ali Mobasheri, et al.. (2022). Osteoarthritis endotype discovery via clustering of biochemical marker data. Annals of the Rheumatic Diseases. 81(5). 666–675. 97 indexed citations breakdown →
4.
McDonald, Thomas, et al.. (2019). Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction. Lab on a Chip. 19(12). 2127–2137. 27 indexed citations
5.
6.
Mobasheri, Ali, Anne‐Christine Bay‐Jensen, Oreste Gualillo, et al.. (2017). Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?. Best Practice & Research Clinical Rheumatology. 31(5). 705–720. 11 indexed citations
7.
Mobasheri, Ali, Anne‐Christine Bay‐Jensen, W.E. van Spil, Jonathan Larkin, & Marc C. Levesque. (2017). Osteoarthritis Year in Review 2016: biomarkers (biochemical markers). Osteoarthritis and Cartilage. 25(2). 199–208. 123 indexed citations
8.
Germaschewski, Fiona, Christopher Matheny, Jonathan Larkin, et al.. (2014). Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients. Osteoarthritis and Cartilage. 22(5). 690–697. 39 indexed citations
9.
Miller, Rachel E., Phuong B. Tran, Shingo Ishihara, Jonathan Larkin, & Anne‐Marie Malfait. (2014). Therapeutic efficacy of anti-adamts5 antibody in the DMM model. Osteoarthritis and Cartilage. 22. S35–S36. 2 indexed citations
10.
11.
Larkin, Jonathan, et al.. (2006). Cytokine-Activated Natural Killer Cells Exert Direct Killing of Hepatoma Cells Harboring Hepatitis C Virus Replicons. Journal of Interferon & Cytokine Research. 26(12). 854–865. 24 indexed citations
12.
Larkin, Jonathan, Gourapura J. Renukaradhya, Venkataraman Sriram, et al.. (2006). CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells. The Journal of Immunology. 177(1). 268–279. 37 indexed citations
13.
Feitelson, Mark A., Jonathan Larkin, & Raymond F. Schinazi. (2004). Hepatitis B Virus Transgenic Severe Combined Immunodeficient Mouse Model of Acute and Chronic Liver Disease. Humana Press eBooks. 96. 269–288. 1 indexed citations
14.
Kirwan, John, Maarten Boers, H A Capell, et al.. (2004). Authors' reply: Low dose prednisolone for treatment of RA. Annals of the Rheumatic Diseases. 63(11). 1533–1534. 2 indexed citations
15.
Larkin, Jonathan, Ling Jin, Mark W. Farmen, et al.. (2003). Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System. Journal of Interferon & Cytokine Research. 23(5). 247–257. 56 indexed citations
16.
Larkin, Jonathan, Marcia M. Clayton, Jie Liu, & Mark A. Feitelson. (2001). Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology. 34(4). 792–797. 43 indexed citations
17.
Larkin, Jonathan, Marcy Clayton, Bill Sun, et al.. (1999). Hepatitis B virus transgenic mouse model of chronic liver disease. Nature Medicine. 5(8). 907–912. 57 indexed citations
18.
Slater, Simon J., Mary Beth Kelly, Jonathan Larkin, et al.. (1997). Interaction of Alcohols and Anesthetics with Protein Kinase Cα. Journal of Biological Chemistry. 272(10). 6167–6173. 78 indexed citations
19.
Slater, Simon J., Cojen Ho, Mary Beth Kelly, et al.. (1996). Protein Kinase Cα Contains Two Activator Binding Sites That Bind Phorbol Esters and Diacylglycerols with Opposite Affinities. Journal of Biological Chemistry. 271(9). 4627–4631. 110 indexed citations
20.
Slater, Simon J., Mary Beth Kelly, Frank J. Taddeo, et al.. (1995). Direct Activation of Protein Kinase C by 1α,25-Dihydroxyvitamin D3. Journal of Biological Chemistry. 270(12). 6639–6643. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdelhamid Liacini Breakdown of academic impact, for papers by Hiroshi Matsushima Breakdown of academic impact, for papers by Bernhard J. Kirschbaum Breakdown of academic impact, for papers by Kazuhiko Yamamura Breakdown of academic impact, for papers by Sally Thomas Breakdown of academic impact, for papers by Pércío S. Gulko Breakdown of academic impact, for papers by Elizabeth A. Chlipala Breakdown of academic impact, for papers by Anne M. Fourie Breakdown of academic impact, for papers by Hirohisa Ogawa Breakdown of academic impact, for papers by Masayuki Tsuchiya
Rankless by CCL
2026